🔎 Trials Near Me

Akèy › Obèsite › Texas › Dallas

Etid klinik pou Obèsite nan Dallas, TX

30 etid pou Obèsite ap chèche patisipan nan sit nan ak bò kote Dallas (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Ap rekriteFaz 2
  • Velocity Clinical Research - Dallas /ID# 282734, Dallas
Laj 18 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT07752979

Spinal Cord Injury Model Systems (SCIMS) - Education Module

Ap rekrite
  • Baylor Scott & White Institute for Research, Dallas
Laj 18 a 70 · Tout sèks · Mizajou Sep 30, 2026 · NCT06003686

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

Ap rekriteFaz 3
  • UT Southwestern Med Center, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07533175

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Ap rekriteFaz 3
  • North Texas Endocrine Center, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07720271

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Ap rekriteFaz 3
  • UT Southwestern Med Center, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07668414

AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight

Ap rekriteFaz 3
  • Velocity Clinical Res-Dallas, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT07339423

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Ap rekriteFaz 3
  • Velocity Clinical Research, Dallas, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Ap rekriteFaz 3
  • UT Southwestern Medical Center, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07392190

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Ap rekriteFaz 3
  • Thyroid Endocrinology and Diabetes, Dallas
  • Soltero Cardiovascular Research Center, Dallas
  • Zenos Clinical Research, Dallas
  • ak 2 plis
Laj 45 a 99 · Tout sèks · Mizajou Sep 22, 2026 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

Ap rekriteFaz 3
  • Velocity Clinical Research, Dallas, Dallas
  • UT Southwestern Medical Center, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07321886

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Ap rekriteFaz 2
  • FutureSearch Trials of Dallas, Dallas
Laj 18 a 75 · Tout sèks · Mizajou Sep 22, 2026 · NCT07589608

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Ap rekriteFaz 3
  • Cedar Health Research, LLC, Dallas
Laj 18 a 99 · Tout sèks · Mizajou Sep 16, 2026 · NCT07037459

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Ap rekriteFaz 3
  • Velocity Clinical Research, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07351058

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Ap rekriteFaz 3
  • University of Texas Southwestern Medical Center - Children's Medical Center Dallas, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07351045

Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight

Ap rekriteFaz 3
  • Cedar Health Research, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07770841

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Ap rekriteFaz 2
  • Velocity Clinical Research, Dallas, Dallas
  • FutureSearch Trials of Dallas, Dallas
Laj 18 a 75 · Tout sèks · Mizajou Sep 8, 2026 · NCT06143956

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Ap rekriteFaz 2
  • Mercy Family Clinic, Dallas
  • Velocity Clinical Research, Dallas, Dallas
Laj 18 a 75 · Tout sèks · Mizajou Sep 8, 2026 · NCT07215559

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Ap rekriteFaz 3
  • Cedar Health Research, LLC, Dallas
Laj 18 a 99 · Tout sèks · Mizajou Sep 3, 2026 · NCT07684235

Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN)

Ap rekriteFaz 1 bonèVolontè an sante akeyi
  • University of Texas Southwestern Medical Center, Dallas
Laj 18 a 55 · Tout sèks · Mizajou Sep 3, 2026 · NCT04838678

Effects of Obesity in the Aged

Ap rekriteVolontè an sante akeyi
  • Institute for Exercise and Environmental Medicine, UT Southwestern and Texas Health Resources, Dallas
Laj 65 a 75 · Tout sèks · Mizajou Sep 2, 2026 · NCT05028309

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Ap rekriteFaz 2
  • University of Texas, Southwestern, Dallas
Laj 7 a 25 · Tout sèks · Mizajou Aug 19, 2026 · NCT05082519

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Ap rekriteFaz 3
  • Renal Disease Research Institute, Dallas
  • Texas Health Heart and Vascular Specialists, Dallas
  • Southwest Family Medicine_Dallas, Dallas
  • ak 1 plis
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT07567001

AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Ap rekriteFaz 3
  • Mercy Family Clinic, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT07509307

A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia

Ap rekriteFaz 2
  • Velocity Clinical Research Dallas, Dallas
Laj 18 a 80 · Tout sèks · Mizajou Jul 22, 2026 · NCT07477704

UTSW NORC Pilot Spinal Cord Injury Dietary Program

Ap rekrite
  • University of Texas Southwestern Medical Center, Dallas
Laj 18 a 65 · Tout sèks · Mizajou Jul 15, 2026 · NCT06924177

Targeting Breathing Limitations to Improve Functional Outcomes in HFpEF

Ap rekriteVolontè an sante akeyi
  • UT Southwestern Medical Center, Dallas
Laj 55 a 90 · Tout sèks · Mizajou May 7, 2026 · NCT05723679

Leg Heating in Pregnant Women With Obesity

Ap rekriteVolontè an sante akeyi
  • UT Southwestern Medical Center; Institute for Exercise and Environmental Medicine, Dallas
Laj 18 a 45 · Fanm · Mizajou Apr 17, 2026 · NCT06932250

Comparing Outcomes Among Children With Obesity in a Community Healthy Lifestyle Program

Ap rekrite
  • University of Texas Southwestern, Children's Health, Dallas
Laj 6 a 14 · Tout sèks · Mizajou Mar 30, 2026 · NCT07342855

Healthy Living BEYOND Weight Study

Ap rekriteEtid obsèvasyon
  • American Heart Association, Dallas
Laj 18 ak plis · Tout sèks · Mizajou Aug 6, 2025 · NCT07075341

Etid Obèsite nan lòt vil

Lòt etid nan Dallas

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.